PL EN


Preferences help
enabled [disable] Abstract
Number of results
2006 | 4 | 4 | 230-240
Article title

Współczesne możliwości oszczędzenia zdolności do rozrodu u kobiet leczonych z powodu nowotworów narządu rodnego

Content
Title variants
EN
Modern therapeutic modalities enabling preservation of procreative potential in women treated for genital malignancies
Languages of publication
EN PL
Abstracts
EN
Recent decade saw a significant progress in the diagnosis of prognostically important features of neoplasm, in particular those influencing critically the choice of techniques and protocols of oncological treatment. Principles of therapeutic approach to patients with genital malignancies, which were valid in the past, most often neither took into consideration the age of patients, nor was the issue of preservation of procreative functions considered as clinically important. In recent years, the situation in this area underwent a dramatic change. In patients of procreative age, the measure of therapeutic success is not as much standard parameters, e.g. long-term survival rate or recurrence risk, but rather overall quality of life and in particular preservation of ability to procreate. At present, in most locations of early-stage female genital malignancy, there is a possibility to spare procreative function. Based on reports in recent publications, we undertook a review of current views on management of malignancies of uterine cervix, uterine mucosa and ovary enabling preservation of procreative potential of women involved.
PL
Ostatnie dziesięciolecie to czas, w którym dokonał się znaczący postęp w rozpoznawaniu istotnych prognostycznie czynników charakteryzujących nowotwór, zwłaszcza tych, które w sposób znaczący wpływają na wybór metody leczenia onkologicznego. Obowiązujące w przeszłości zasady postępowania terapeutycznego stosowane w leczeniu nowotworów złośliwych narządu rodnego najczęściej nie uwzględniały wieku pacjentek i możliwości oszczędzenia funkcji rozrodczych jako istotnego klinicznie elementu. Sytuacja w tym zakresie uległa w ostatnich latach zasadniczej zmianie. U chorych w wieku rozrodczym miarą sukcesu terapeutycznego są obecnie nie tylko typowe parametry, jak odsetek wieloletnich przeżyć czy też ryzyko nawrotu, ale również jakość życia – w tym szczególnie zachowanie zdolności do rozrodu. Obecnie w większości lokalizacji wczesnych postaci nowotworów narządów płciowych kobiecych istnieje możliwość oszczędzenia zdolności do prokreacji. Bazując na doniesieniach współczesnego piśmiennictwa, dokonano przeglądu aktualnych stanowisk i opinii na leczenie nowotworów szyjki macicy, błony śluzowej macicy oraz jajnika z oszczędzeniem zdolność do rozrodu.
Discipline
Year
Volume
4
Issue
4
Pages
230-240
Physical description
References
  • 1. Zatoński W, Tyczyński J.: Nowotwory złośliwe w Polsce w 1996 roku. Centrum Onkologii - Instytut im. M. Skło-dowskiej-Curie. Zakład Epidemiologii Nowotworów. Krajowy Rejestr Nowotworów, Warszawa 1999.
  • 2. Krivak T.C.: Adenocarcinoma in situ; a systematic review of therapeutic options and predictors of persistent or recurrent disease. Obstet. Gynecol. Survey 2001; 56: 576-575.
  • 3. Tay E.H., Yews WS., Ho T.H.: Management of adenocarcinoma in situ (ACIS) of the cervix - a clinical dilemma. Singapore Med. J. 1999; 40: 36-39.
  • 4. Koliopoulos G., Sotiriadis A., Kyrgiou M. i wsp.: Conservative surgical methods for FIGO stage IA2 squamous cell cervical carcinoma and their role in preserving women’s fertility. Gynecol. Oncol. 2004; 93: 469-473.
  • 5. Ungar L., Palfalvi L., Hogg R. i wsp.: Abdominal radical trachelectomy: a fertility preserving option for women with early cervical cancer. BjOg 2005; 112: 366-369.
  • 6. Hatami M., Del Priore G., Chudnoff S.G. i wsp.: Preserving fertility in invasive cervical adenocarcinoma by abdominal radical trachelectomy and pelvic lymphadenec-tomy. Arc. Iran Med. 2006; 9: 413-416.
  • 7. Smith J.R., Boyle D.C., Corless D.J. i wsp.: Abdominal radical trachelectomy: a new surgical technique for the conservative management of cervical carcinoma. Br. J. Obstet. Gynaecol. 1997; 104: 1196-1200.
  • 8. Shepherd J.H., Crawford R.A., Oram D.H.: Radical tra-chelectomy: a way to preserve fertility in the treatment of early cervical cancer. Br. J. Obstet. Gynaecol. 1998; 105: 912-916.
  • 9. Shen K., Lang J.H., Yang JX iwsp.: Analysis of 16 patients with early cervical cancer treated by laparoscopic vaginal radical trachelectomy. Zhonghua Fu Chan Ke Za Zhi 2006;41:222-225.
  • 10. Plante M., Renaud M.C., Hoskins IA iwsp.: Vaginal radical trachelectomy: a valuable fertility - preserving option in the management of early - stage cervical cancer. A series of 50 pregnancies and review of the literature. Gynecol. Oncol. 2005; 98: 3-10.
  • 11. Krauss T., Huschmand Nia A., Viereck V. i wsp.: New developments in the treatment of cervical cancer. Onkologie 2001; 24: 340-345.
  • 12. Roy M., Plante M.: Pregnancies after radical vaginal tra-chelectomy for early-stage cervical cancer. Am. J. Obstet. Gynaecol. 1998; 179: 1491-1496.
  • 13. Zanetta G., Fei F., Mangioni C.: Chemotherapy with pacli-taxel, ifosfamide and cisplatin for the treatment of squamous cell cervical cancer: The experience of Monza. Semin. Oncol. 2000; 27 (supl. 1): 23-27.
  • 14. Kurman R.J., Kaminski P.F., Norris H.J.: The behaviour of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 1985; 56: 403-412.
  • 15. Tavassoli F.A., Kraus F.T.: Endometrial lesions in uteri resected for atypical endometrial hyperplasia. Am. J. Clin. Pathol. 1978; 70: 770-779.
  • 16. Gotlieb WH., Beiner M.E., Shalmon B. i wsp.: Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet. Gynecol. 2003: 102: 718-725.
  • 17. Gershenson D.M.: Fertility-sparing surgery for malignancies in women. J. Natl. Cancer Inst. Monogr. 2005; 34: 43-47.
  • 18. Juretzka M.M., O’Hanlan K.A., Katz S.L. iwsp.: Embryo cryopreservation after diagnosis of stage IIB endometrial cancer and subsequent pregnancy in a gestational carrier. Fertil. Steril. 2005; 83: 1041.
  • 19. Ravel A., Safran A., Benshushan A. iwsp.: In vitro maturation and fertilization of oocytes from an intact ovary of a surgically treated patient with endometrial carcinoma: case report. Hum. Reprod. 2004; 19: 1608-1611.
  • 20. Ronetti B.M., Kajdacsy-Balla A., Glicks C.B. iwsp.: Mucinous borderline ovarian tumours: point of general agreement and persistent controversies regarding nomenclature, diagnostic criteria and behaviour. Hum. Pathol. 2004; 35: 949-960.
  • 21. Seidman J.D., Soslow R.A., Vang R. i wsp.: Borderline ovarian tumours: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum. Pathol. 2004; 35: 918-933.
  • 22. Bell D.A., Langacre TA., Prat J. i wsp.: Serous borderline (low malignant potential, atypical proliferative) ovarian tumours: workshop perspective. Hum. Pathol. 2004; 35: 934-948.
  • 23. Bostwick G., Tazelaar H.D., Ballon S. i wsp.: Ovarian epithelial tumours of borderline malignancy - a clinical and pathologic study of 109 cases. Cancer 1986; 58:2052-2065.
  • 24. Limh-Tan S.K., Cajigas H.E., Scully R.E.: Ovarian cystectomy for serous borderline tumours: a follow up study of 35 cases. Obstet. Gynecol. 1988; 72: 775-780.
  • 25. Seidman J.D., Kurman R.J.: Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumours). Cancer 2002; 95: 675-676.
  • 26. Gotlieb WH., Flikker S., Davidson B. i wsp.: Borderline tumours of the ovary: fertility treatment, conservative management and pregnancy outcome. Cancer 1998; 82:141-146.
  • 27. Heintz A.P, Odicino F., Maisonneuve P. i wsp.: Carcinoma of the ovary. J. Epidemiol. Biostatistic 2001; 6: 113-114.
  • 28. Beiner M.E., Gotlieb WH., Davidson B. i wsp.: Infertility treatment after conservative management of borderline ovarian tumours. Cancer 2001; 92: 320-325.
  • 29. Tinelli R., Tinelli A., Tinelli F. i wsp.: Conservative surgery for borderline ovarian tumours: a review. Gynecol. Oncol. 2006; 100: 185-191.
  • 30. Maneo A., Vignali M., Chiari M.: Are borderline tumours of the ovary safely treated by laparoscopy? Gynecol. Oncol. 2004; 94: 387-339.
  • 31. Duska L.R., Chang Y., Flyn C.E. i wsp.: Epithelial ovarian cancer in the reproductive age group. Cancer 1999; 85: 2623-2629.
  • 32. Rodriguez M., Nguyen H.N., Averette H.E. i wsp.: National survey of ovarian carcinoma XII. Epithelial ovarian malignancies in women less than or equal to 25 years of age. Cancer 1994; 73: 1245-1250.
  • 33. DiSaia P.J.: Fertility-sparing treatment of patients with ovarian cancer. Comprehens. Ther. 1990; 16: 35-42.
  • 34. Low J.J., Perrin L.C., Crandon A.J., Hacker N.F.: Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumours. Cancer 2000; 89: 391-398.
  • 35. Zanetta G., Bonazzi C., Cantu M. i wsp.: Survival and reproductive function after treatment of malignant germ cell ovarian tumours. J. Clin. Oncol. 2001; 19: 1015-1020.
  • 36. Morice P., Camatte S., El Hassan J. i wsp.: Clinical outcomes and fertility after conservative treatment of ovarian borderline tumours. Fertil. Steril. 2001; 75: 92-96.
  • 37. Miyazaki T., Tomoda Y., Ohta M. i wsp.: Preservation of ovarian function and reproductive ability in patients with malignant ovarian tumours. Gynecol. Oncol. 1988; 30: 329-341.
  • 38. Raspagliesi F., Fontanelli R., Paladini D., di Re E.M.: Conservative surgery in high-risk epithelial ovarian carcinoma. J. Am. Col. Surg. 1997; 185: 457-460.
  • 39. Gonzalez-Lira G., Escudero-De Los Rios P., Salazar-Martinez E., Lazcano-Ponce E.C.: Conservative surgery for ovarian cancer and effect on fertility. Int. J. Gynaecol. Obstet. 1997; 56: 155-162.
  • 40. Piver M.S., Barlow J.J., Lele S.B.: Incidence of subclinical metastasis in stage I and II ovarian carcinoma. Obstet. Gynecol. 1978; 52: 100-104.
  • 41. Colombo N., Chiari S., Maggioni A. i wsp.: Controversial issues in the management of early epithelial ovarian cancer: conservative surgery and role of adjuvant therapy. Gynecol. Oncol. 1994; 55: 457-451.
  • 42. Trimbos J.B., Parmar M., Vergote I. i wsp.: International Collaborative Ovarian Neoplasm Trial: two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. J. Natl. Cancer Inst. 2003; 95: 105-112.
  • 43. Williams T.J., Dockerty M.B.: Status of the contralateral ovary in encapsulated low grade malignant tumours of the ovary. Surg. Gynecol. Obstet. 1976; 143: 763-766.
  • 44. Young R.C.: Three cycles versus six cycles of adjuvant paclitaxel (taxol)/ carboplatin in early stage ovarian cancer. Semin. Oncol. 2000; 27: 8-10.
Document Type
article
Publication order reference
YADDA identifier
bwmeta1.element.psjd-6aeb87f0-6f3e-4e1e-8e5b-618981bb565d
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.